| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Director
3 companies
Berns Paul L is a See Remarks at Neumora Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 11 sells.
Estimated insider holdings value: $15.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | NMRA Neumora Therapeutics, Inc. | See Remarks | Sell | 13,871 | $1.69 | $23,468.34 | -0.2% | -60.1% | +107.5% | |
| Aug 5, 2021 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 1,450 | $154.00 | $223,300.00 | -14.9% | -7.8% | +3.5% | |
| Nov 4, 2020 | JAZZ Jazz Pharmaceuticals Plc | Director | Sale+OE | 4,691 | $150.42 | $705,603.66 | -11.2% | - | - | |
| Aug 7, 2020 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 931 | $125.87 | $117,185.44 | -8.7% | - | - | |
| Aug 9, 2019 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 726 | $135.65 | $98,481.10 | -8.4% | - | - | |
| Aug 10, 2018 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 660 | $176.61 | $116,563.19 | -8.9% | - | - | |
| Aug 11, 2017 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 662 | $142.37 | $94,247.63 | -5.3% | - | - | |
| Aug 15, 2016 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 633 | $136.45 | $86,372.85 | -10.8% | - | - | |
| Apr 20, 2016 | CLRB Cellectar Biosciences, Inc. | Director | Buy | 117,371 | $2.12 | $248,826.52 | New | - | - |